Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare study-Reference-Cited by-同舟云学术

Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare study

Published:2019-05-23 Issue:8 Volume:8 Page:3918-3927
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Bishnoi Rohit¹^ORCID,Hong Young‐Rock²^ORCID,Shah Chintan¹,Ali Azka¹,Skelton William P.¹,Huo Jinhai²^ORCID,Dang Nam H.¹,Dang Long H.¹

Affiliation:

1. Division of Hematology and Oncology, Department of Medicine University of Florida Gainesville FL

2. Department of Health Services Research, Management and Policy, College of Public Health and Health Professions University of Florida Gainesville FL

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2278

Reference21 articles.

1. The role of CD26/dipeptidyl peptidase IV in cancer

2. CD26/dipeptidyl peptidase IV and its role in cancer;Pro B;Histol Histopathol,2004

3. DPPIV/CD26: a tumor suppressor or a marker of malignancy?

4. DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness

5. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic Antitumor and Apoptotic Activity of Sitagliptin or Linagliptin Plus Cisplatin Against A549 Lung Cancer Cells (an Invitro Study);Journal of Contemporary Medical Sciences;2024-07-02

2. Impact of DPP4 Inhibition on Survival in Patients With Metastatic Renal Cell Carcinoma and Type 2 Diabetes Mellitus;Clinical Genitourinary Cancer;2024-07

3. Non-Insulin Antidiabetic Agents and Lung Cancer Risk in Drug-Naive Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study;Cancers;2024-06-28

4. Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention;Cancers;2024-03-28

5. Cancer biology in diabetes update: Focusing on antidiabetic drugs;Journal of Diabetes Investigation;2024-03-08